Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Powderly

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Medical Mycology|October 16, 2019
Risk factors predicting Candida infective endocarditis in patients with candidemiaKap Sum Foong, Abby Sung, Jason P Burnham, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2019
MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasisAndrej Spec, John Pullman, George R Thompson, et al.
American Journal of Epidemiology|December 22, 2020
The Clinical Course of Coronavirus Disease 2019 in a US Hospital System: A Multistate AnalysisAaloke Mody, Patrick G Lyons, Cristina Vazquez Guillamet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2022
The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern EraPatrick B Mazi, John M Sahrmann, Margaret A Olsen, et al.
Annals of Internal Medicine|July 18, 2002
Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDSPhilip C Johnson, L Joseph Wheat, Gretchen A Cloud, et al.
The Lancet. Infectious Diseases|September 29, 2019
Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort studyCarlos Mejia-Chew, Jane A O'Halloran, Margaret A Olsen, et al.
AIDS (London, England)|April 23, 2008
Insulin resistance predicts endothelial dysfunction and cardiovascular risk in HIV-infected persons on long-term highly active antiretroviral therapyKristin E Mondy, Lisa de las Fuentes, Alan Waggoner, et al.
The Journal of Infectious Diseases|January 15, 2004
Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1Daniel R Kuritzkes, Jeffrey Jacobson, William G Powderly, et al.
Metabolism: Clinical and Experimental|May 7, 2005
Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapyJuan Chaparro, Dominic N Reeds, Weidong Wen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2020
Understanding Drivers of Coronavirus Disease 2019 (COVID-19) Racial Disparities: A Population-Level Analysis of COVID-19 Testing Among Black and White PopulationsAaloke Mody, Kristin Pfeifauf, Cory Bradley, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Medical Mycology|October 16, 2019
Risk factors predicting Candida infective endocarditis in patients with candidemiaKap Sum Foong, Abby Sung, Jason P Burnham, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2019
MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasisAndrej Spec, John Pullman, George R Thompson, et al.
American Journal of Epidemiology|December 22, 2020
The Clinical Course of Coronavirus Disease 2019 in a US Hospital System: A Multistate AnalysisAaloke Mody, Patrick G Lyons, Cristina Vazquez Guillamet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2022
The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern EraPatrick B Mazi, John M Sahrmann, Margaret A Olsen, et al.
Annals of Internal Medicine|July 18, 2002
Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDSPhilip C Johnson, L Joseph Wheat, Gretchen A Cloud, et al.
The Lancet. Infectious Diseases|September 29, 2019
Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort studyCarlos Mejia-Chew, Jane A O'Halloran, Margaret A Olsen, et al.
AIDS (London, England)|April 23, 2008
Insulin resistance predicts endothelial dysfunction and cardiovascular risk in HIV-infected persons on long-term highly active antiretroviral therapyKristin E Mondy, Lisa de las Fuentes, Alan Waggoner, et al.
The Journal of Infectious Diseases|January 15, 2004
Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1Daniel R Kuritzkes, Jeffrey Jacobson, William G Powderly, et al.
Metabolism: Clinical and Experimental|May 7, 2005
Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapyJuan Chaparro, Dominic N Reeds, Weidong Wen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2020
Understanding Drivers of Coronavirus Disease 2019 (COVID-19) Racial Disparities: A Population-Level Analysis of COVID-19 Testing Among Black and White PopulationsAaloke Mody, Kristin Pfeifauf, Cory Bradley, et al.
Pageof 15